Tower Research Capital (TRC)’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111K | Buy |
3,511
+2,711
| +339% | +$85.7K | ﹤0.01% | 2294 |
|
|
2025
Q1 | $26.6K | Sell |
800
-3,059
| -79% | -$102K | ﹤0.01% | 2707 |
|
|
2024
Q4 | $133K | Sell |
3,859
-251
| -6% | -$8.64K | ﹤0.01% | 1987 |
|
|
2024
Q3 | $164K | Sell |
4,110
-8,351
| -67% | -$334K | ﹤0.01% | 1801 |
|
|
2024
Q2 | $376K | Buy |
12,461
+12,196
| +4,602% | +$368K | 0.01% | 1578 |
|
|
2024
Q1 | $8.9K | Sell |
265
-5,972
| -96% | -$201K | ﹤0.01% | 3936 |
|
|
2023
Q4 | $201K | Buy |
6,237
+3,666
| +143% | +$118K | ﹤0.01% | 2096 |
|
|
2023
Q3 | $84.3K | Buy |
2,571
+1,913
| +291% | +$62.7K | ﹤0.01% | 2108 |
|
|
2023
Q2 | $23.2K | Sell |
658
-4,709
| -88% | -$166K | ﹤0.01% | 3230 |
|
|
2023
Q1 | $175K | Buy |
5,367
+5,098
| +1,895% | +$166K | 0.01% | 1443 |
|
|
2022
Q4 | $14K | Sell |
269
-1,669
| -86% | -$86.9K | ﹤0.01% | 3508 |
|
|
2022
Q3 | $86K | Buy |
1,938
+549
| +40% | +$24.4K | ﹤0.01% | 2692 |
|
|
2022
Q2 | $68K | Buy |
1,389
+1,108
| +394% | +$54.2K | ﹤0.01% | 2605 |
|
|
2022
Q1 | $14K | Sell |
281
-203
| -42% | -$10.1K | ﹤0.01% | 3889 |
|
|
2021
Q4 | $21K | Buy |
484
+38
| +9% | +$1.65K | ﹤0.01% | 3602 |
|
|
2021
Q3 | $17K | Sell |
446
-1,266
| -74% | -$48.3K | ﹤0.01% | 3866 |
|
|
2021
Q2 | $48K | Buy |
1,712
+1,198
| +233% | +$33.6K | ﹤0.01% | 3053 |
|
|
2021
Q1 | $17K | Buy |
514
+308
| +150% | +$10.2K | ﹤0.01% | 4006 |
|
|
2020
Q4 | $7K | Sell |
206
-3,034
| -94% | -$103K | ﹤0.01% | 4488 |
|
|
2020
Q3 | $110K | Buy |
+3,240
| New | +$110K | ﹤0.01% | 3086 |
|